Zobrazeno 1 - 10
of 19
pro vyhledávání: '"Jeng-Shiuan Tsai"'
Autor:
Chien‐Yu Lin, Chia‐Hao Hu, Chia‐Fu Hsu, Jeng‐Shiuan Tsai, Chian‐Wei Chen, Chia‐Yin Lin, Chao‐Chun Chang, Yi‐Ting Yen, Yau‐Lin Tseng, Po‐Lan Su, Chien‐Chung Lin
Publikováno v:
Thoracic Cancer, Vol 14, Iss 19, Pp 1857-1864 (2023)
Abstract Background Some prospective studies have shown that second‐generation tyrosine kinase inhibitors (TKIs) provide better control in patients with non‐small cell lung cancer (NSCLC) with uncommon epidermal growth factor receptor (EGFR) muta
Externí odkaz:
https://doaj.org/article/7e94a69bce074dac9987c9d9a0641cf8
Autor:
Chin-Wei Kuo, Po-Lan Su, Tang-Hsiu Huang, Chien-Chung Lin, Chian-Wei Chen, Jeng-Shiuan Tsai, Xin-Min Liao, Tzu-Yi Chan, Chi-Chang Shieh
Publikováno v:
Scientific Reports, Vol 13, Iss 1, Pp 1-13 (2023)
Abstract Alveolar macrophages (AMs) are the drivers of pulmonary cytokine storm in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. This study aimed to investigate clinical–regulatory factors for the entrance protein of SARS-
Externí odkaz:
https://doaj.org/article/8979b424ecc844029895d652098ff14d
Autor:
Chang-Yao Chu, Chien-Yu Lin, Chien-Chung Lin, Chien-Feng Li, Shang-Yin Wu, Jeng-Shiuan Tsai, Szu-Chun Yang, Chian-Wei Chen, Chia-Yin Lin, Chao-Chun Chang, Yi-Ting Yen, Yau-Lin Tseng, Po-Lan Su, Wu-Chou Su
Publikováno v:
Scientific Reports, Vol 13, Iss 1, Pp 1-13 (2023)
Abstract The role of Programmed Cell Death Ligand 1 (PD-L1) expression in predicting epidermal growth factor receptor tyrosine kinase inhibitor (EGFR-TKIs) efficacy remains controversial. Recent studies have highlighted that tumor-intrinsic PD-L1 sig
Externí odkaz:
https://doaj.org/article/83cd94bc8c05488fbcc304f0efe0162e
Autor:
Chin-Wei Kuo, Chien-Yu Lin, Sheng-Huan Wei, Yun-Tse Chou, Chian-Wei Chen, Jeng-Shiuan Tsai, Po-Lan Su, Chien-Chung Lin
Publikováno v:
Therapeutic Advances in Medical Oncology, Vol 15 (2023)
Background: Invasive pulmonary aspergillosis (IPA) can negatively impact cancer patients’ survival. It remains uncertain whether IPA’s impact on patient outcomes varies by treatment approach in advanced lung cancer. Objectives: To explore the ass
Externí odkaz:
https://doaj.org/article/e5f40e36b0f44c21a944f1256d1f3e63
Autor:
Chian-Wei Chen, Chien-Yu Lin, Jeng-Shiuan Tsai, Chia-Yin Lin, Chao-Chun Chang, Yi-Ting Yen, Yau-Lin Tseng, Po-Lan Su, Chien-Chung Lin
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
Although combination therapy including chemotherapy and immune checkpoint inhibitors (ICIs) improves overall survival (OS) of patients with non-small-cell lung cancer (NSCLC), there is a higher incidence of adverse events and treatment discontinuatio
Externí odkaz:
https://doaj.org/article/784fdc84b5bb4aefad8eabe1f2ae8ca2
Autor:
Po-Lan Su, Jung-Yueh Chen, Chang-Yao Chu, Yi-Lin Chen, Wan-Li Chen, Kuan-Yu Lin, Chung-Liang Ho, Jeng-Shiuan Tsai, Szu-Chun Yang, Chian-Wei Chen, Yi-Lin Wu, Yau-Lin Tseng, Chao-Chun Chang, Yi-Ting Yen, Chia-Ying Lin, Chien-Chung Lin, Wu-Chou Su
Publikováno v:
Scientific Reports, Vol 12, Iss 1, Pp 1-9 (2022)
Abstract Neoadjuvant immunotherapy and chemotherapy have improved the major pathological response (MPR) in patients with early-stage operable non-small cell lung cancer (NSCLC). This study aimed to assess whether the presence of targetable driver mut
Externí odkaz:
https://doaj.org/article/249de0c14737440c9d0617b01e951b12
Autor:
Jeng-Shiuan Tsai, Po-Lan Su, Szu-Chun Yang, Chao-Chun Chang, Chia-Ying Lin, Yi-Ting Yen, Yau-Lin Tseng, Wu-Wei Lai, Chien-Chung Lin, Wu-Chou Su
Publikováno v:
Journal of the Formosan Medical Association, Vol 120, Iss 9, Pp 1729-1739 (2021)
Background: Recent study showed that the combination of erlotinib and bevacizumab had better disease control than erlotinib monotherapy in patients with advanced epidermal growth factor receptor (EGFR)-mutant non-small cell lung cancer (NSCLC). Howev
Externí odkaz:
https://doaj.org/article/d3ab35ae0f7a49adaae54f42acf65554
Autor:
Jeng-Shiuan Tsai, Sheng-Huan Wei, Chian-Wei Chen, Szu-Chun Yang, Yau-Lin Tseng, Po-Lan Su, Chien-Chung Lin, Wu-Chou Su
Publikováno v:
Pharmaceuticals, Vol 15, Iss 11, p 1407 (2022)
The use of immune checkpoint inhibitors (ICIs) has provided overall survival (OS) benefits in patients with treatment-naïve advanced non-small cell lung cancer (NSCLC) without targetable driver mutations. However, studies comparing ICIs monotherapy
Externí odkaz:
https://doaj.org/article/22fa43d48459485ea5cdf796ce0f8c31
Autor:
Jeng-Shiuan Tsai, 蔡政烜
99
With the development of optical measurement, the method of displace measurement for micro position has gradually attach importance to non-contact type. Among the methods, Laser Doppler measurement system has advantages of non-invasive, real t
With the development of optical measurement, the method of displace measurement for micro position has gradually attach importance to non-contact type. Among the methods, Laser Doppler measurement system has advantages of non-invasive, real t
Externí odkaz:
http://ndltd.ncl.edu.tw/handle/94727872792376650995
Autor:
Chien‐Yu Lin, Chia‐Hao Hu, Chia‐Fu Hsu, Jeng‐Shiuan Tsai, Chian‐Wei Chen, Chia‐Yin Lin, Chao‐Chun Chang, Yi‐Ting Yen, Yau‐Lin Tseng, Po‐Lan Su, Chien‐Chung Lin
Publikováno v:
Thoracic Cancer.